West End Advisors, LLC Biogen Inc. Transaction History

West End Advisors, LLC

$4.06 Billion
Q3 2024

A detailed history of West End Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, West End Advisors, LLC holds 2 shares of BIIB stock, worth $300. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 2 -0.0%

Holding current value

$300

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	BUY	$253.3 - $285.89 $506 - $571	2 New	2 $0
Q2 2022 Jul 28, 2022	BUY	$187.54 - $223.02 $187 - $223	1 Added 100.0%	2 $407,000
Q2 2021 Jul 15, 2021	BUY	$259.0 - $414.71 $259 - $414	1 New	1 $346,000
Q2 2019 Jul 23, 2019	SELL	$219.29 - $241.72 $24.1 Million - $26.6 Million	-109,859 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$216.71 - $338.96 $351,286 - $549,454	1,621 Added 1.5%	109,859 $26 Billion
Q4 2018 Jan 30, 2019	BUY	$278.5 - $352.75 $972,800 - $1.23 Million	3,493 Added 3.33%	108,238 $32.6 Billion
Q3 2018 Nov 07, 2018	SELL	$293.51 - $383.83 $5.54 Million - $7.24 Million	-18,868 Reduced 15.26%	104,745 $37 Billion
Q2 2018 Jul 26, 2018	SELL	$257.52 - $306.91 $2.36 Million - $2.82 Million	-9,174 Reduced 6.91%	123,613 $35.9 Billion
Q1 2018 May 08, 2018	SELL	$260.13 - $367.91 $1.45 Million - $2.05 Million	-5,561 Reduced 4.02%	132,787 $36.4 Billion
Q4 2017 Feb 02, 2018	SELL	$307.64 - $344.58 $12.5 Million - $14 Million	-40,710 Reduced 22.74%	138,348 $44.1 Billion
Q3 2017 Nov 03, 2017	SELL	$281.15 - $329.69 $2.97 Million - $3.49 Million	-10,572 Reduced 5.58%	179,058 $56.1 Billion
Q2 2017 Aug 09, 2017	BUY	N/A	189,630	189,630 $51.5 Billion

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of West End Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West End Advisors, LLC with notifications on news.

Account

West End Advisors, LLC Biogen Inc. Transaction History